CLINICAL_TRIALS
trial_result
· 2012-09-25
Clinical Trial Update: Phase II Proof-of-concept Study of APD421 [Phase 2]
Summary
A Phase II proof-of-concept study of APD421 for chemotherapy-induced nausea and vomiting has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: COMPLETED